Dudediligence.

BioRestorative Therapies, Inc

BRTXNASDAQ · Services-Misc Health & Allied Services, NEC
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$89,100Jun ’24$233,600Sep ’24$43,300Dec ’24$25,000Mar ’25$303,300Jun ’25$11,800Sep ’25$19,600Dec ’25$23,170Mar ’26
Net income, by quarter
−$4.0MJun ’24−$1.1MSep ’24−$1.6MDec ’24−$5.3MMar ’25−$2.7MJun ’25−$3.0MSep ’25−$3.2MDec ’25−$2.2MMar ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$46,000$119,800$145,800$401,000$359,700
Gross profitnone on filenone on file$145,800$372,928$335,856
Operating income−$26.3M−$19.0M−$15.2M−$11.6M−$15.6M
Net income−$44.3M−$13.2M−$10.4M−$9.0M−$14.2M
Operating cash flow−$3.3M−$5.9M−$6.4M−$8.2M−$10.8M
Free cash flow−$3.4M−$6.2M−$6.6M−$8.3M−$10.9M
Cash$21.0M$1.7M$884,377$547,890$1.5M
Debt$250,000none on filenone on filenone on filenone on file
Shares outstanding3.5M3.7M4.7M6.9M8.9M